Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.
Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.
复制标题
通过聚肌苷:聚胞苷酸预防气道同种异体移植耐受需要 I 型干扰素对小鼠气道闭塞的反应性。
DOI:
10.1016/j.healun.2013.06.017
复制
发表时间:
2013
期刊:
影响因子:
--
通讯作者:
McDyer,JohnF
中科院分区:
文献类型:
--
作者:
Miller,HannahL;Shah,PaliD;Orens,JonathanB;McDyer,JohnF
BACKGROUNDRespiratory RNA viruses are associated with bronchiolitis obliterans syndrome (BOS) in lung transplant recipients (LTRS), however the immune mechanisms that regulate airway obliteration remain incompletely understood.METHODSUsing the mouse heterotopic tracheal transplant (HTT) model of obliterative airway disease (OAD), we studied the role of dsRNA using (polyinosinic:polycytidylic acid; poly(I:C)), a synthetic analog of viral dsRNA, in abrogating airway allograft tolerance established with donor-specific transfusion (DST) and anti-CD154 mAb therapy.RESULTSWild-type (WT) B6 recipients of accepted BALB/c airway grafts demonstrated significantly reduced intragraft CD8+ T-cells with markedly impaired allospecific IFN-γ and TNF-α secretion, uncoupled from an activated phenotype and evidence of proliferation. Administration of poly(I:C) to DST/anti-CD154-treated recipients restored OAD pathology and CD8+ alloeffector responses to levels observed in untreated mice. However, B6 IFNαβR−/− recipients were resistant to the abrogation of tolerance mediated by poly(I:C) and did not develop CD8+ alloeffector responses or OAD. Further, adoptive transfers of either WT CD8+ T-cells or CD11c+ dendritic cells (DC) alone into B6 IFNαβR−/− recipients treated with poly(I:C) and DST/anti-CD154 were incapable of abrogating airway graft tolerance.CONCLUSIONSTogether, these data indicate abrogation of DST/anti-CD154-induced airway allograft tolerance via dsRNA requires type-I IFN responsiveness for mouse airway obliteration.
登录
查看更多内容
DOI:
10.1165/rcmb.2007-0257rc
发表时间:
2007-12-01
影响因子:
6.4
作者:
Okazaki, Mikio;Gelman, Andrew E.;Kreisel, Daniel
通讯作者:
Kreisel, Daniel
影响因子:
8.8
作者:
Kumar, D;Erdman, D;Humar, A
通讯作者:
Humar, A
DOI:
10.1172/jci24233
发表时间:
2005-05
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
J. Belperio;M. Keane;M. Burdick;B. Gomperts;Y. Xue;Kurt M. Hong;J. Mestas;A. Ardehali;B. Mehrad;R. Saggar;J. Lynch;D. Ross;R. Strieter
通讯作者:
J. Belperio;M. Keane;M. Burdick;B. Gomperts;Y. Xue;Kurt M. Hong;J. Mestas;A. Ardehali;B. Mehrad;R. Saggar;J. Lynch;D. Ross;R. Strieter
影响因子:
4.4
作者:
Zhai, Y;Shen, XD;Kupiec-Weglinski, JW
通讯作者:
Kupiec-Weglinski, JW
DOI:
10.1084/jem.189.5.821
发表时间:
1999-03-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Cella M;Salio M;Sakakibara Y;Langen H;Julkunen I;Lanzavecchia A
通讯作者:
Lanzavecchia A